Aeras Global TB Vaccine Foundation
The Aeras Global TB Vaccine Foundation was an American non-profit product development organization based in Rockville, Maryland.
Aeras worked to develop vaccines against tuberculosis with a number of partners including adenoviral vector vaccines with Crucell (now known as Janssen) and second-generation fusion-protein vaccines with Statens Serum Institut.
History
Aeras was founded in 1997 to “help develop new concepts and tools to control the global TB epidemic.”1)
In February 2004, Aeras received a 5-year US$82.9 million grant from the Bill & Melinda Gates Foundation. Aeras and the Gates Foundation co-funded an “infant and adolescent TB Vaccine Site preparation study” alongside the European & Developing Countries Clinical Trials Partnership (EDCCTP) at the Infectious Diseases Institute in Uganda.2)
Organization
Aeras was partnered with the Medicines for Malaria Venture to develop antimicrobial products.3)
Personnel
Funding
- China National Biotec Group (CNBG)
Network
Participants in Aeras' clinical trial network included:
- HIV Vaccine Trials Network (HVTN)
- Kenya Medical Research Institute (KEMRI)
- Wits Reproductive Health and HIV Institute (Wits RHI)